CSL Limited
CSL
Rank in Stocks
#368
CSL Limited operates as a global biopharmaceutical company, engaged in the... CSL Limited operates as a global biopharmaceutical company, engaged in the research, development, manufacturing, marketing, and distribution of diverse pharmaceutical and allied products. Its extensive international footprint includes key markets such as Australia, the United States, Germany, the United Kingdom, Switzerland, and China. The company is structured into two principal operating segments: CSL Behring and CSL Seqirus. CSL Behring focuses on plasma-derived therapies, encompassing both plasma products and recombinant treatments. This segment also conducts significant research into both plasma and non-plasma therapeutics and derives revenue from intellectual property licensing and royalties. In contrast, CSL Seqirus is dedicated to the manufacturing and worldwide distribution of non-plasma biotherapeutic products, alongside developing a range of influenza-related solutions. Founded in 1916, CSL Limited maintains its corporate headquarters in Parkville, Australia.
Share Price
$136.37
Market Cap
$65.44B
Change (1 day)
-0.53%
Change (1 year)
-3.98%
Country
AU
Trade CSL Limited (CSL)
Category
Healthcare
Operating Margin for CSL Limited (CSL)
Operating Margin as of October 2026 TTM: 25.57%
According to CSL Limited latest financial reports and stock price the company's current Operating Margin (TTM) is 25.57%. At the end of 2024 the company had an Operating Margin of 18.82%.
Operating Margin history for CSL Limited from 2000 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 25.57% | 33.32% |
| 2025 | 19.18% | 1.91% |
| 2024 | 18.82% | 17.92% |
| 2023 | 15.96% | -27.68% |
| 2022 | 22.07% | -11.97% |
| 2021 | 25.07% | 4.98% |
| 2020 | 23.88% | -17.28% |
| 2019 | 28.87% | 22.59% |
| 2018 | 23.55% | 27.09% |
| 2017 | 18.53% | 11.02% |
| 2016 | 16.69% | -35.98% |
| 2015 | 26.07% | 2.64% |
| 2014 | 25.40% | 10.82% |
| 2013 | 22.92% | 13.69% |
| 2012 | 20.16% | -7.48% |
| 2011 | 21.79% | -9.25% |
| 2010 | 24.01% | 30.70% |
| 2009 | 18.37% | 6.55% |
| 2008 | 17.24% | 0.23% |
| 2007 | 17.20% | 1,146.38% |
| 2006 | 1.38% | -84.17% |
| 2005 | 8.72% | 448.43% |
| 2004 | 1.59% | -63.95% |
| 2003 | 4.41% | -49.60% |
| 2002 | 8.75% | -193.38% |
| 2001 | -9.37% | 0.00% |
| 2000 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -98.49% |
US
|
|
| -149.01% | -105.83% |
US
|
|
| 0.00% | - |
CH
|
|
| 28.81% | -98.87% |
NL
|
|
| 31.23% | -98.78% |
BE
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.